BridgeBio Pharma, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Palo Alto, CA
SEC filing record 1 source field available
Fiscal year end
31 December
BridgeBio Pharma, Inc. has filed 814 SEC EDGAR filings since 19 Jun 2018

SEC filing history

Showing 301-325 of 814 matching filings.

Per page
25
Current page
13
4

4

Filing date
14 Mar 2024
Reporting date
12 Mar 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
14 Mar 2024
Reporting date
12 Mar 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-271650

424B5

Filing date
06 Mar 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
05 Mar 2024
Reporting date
01 Mar 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-271650

424B5

Filing date
04 Mar 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
21 Feb 2024
Reporting date
16 Feb 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
21 Feb 2024
Reporting date
16 Feb 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
21 Feb 2024
Reporting date
16 Feb 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
20 Feb 2024
Reporting date
15 Feb 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-91059

SC 13G/A

Filing date
16 Feb 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-38959

144 filing

Filing date
15 Feb 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-91059

SCHEDULE 13G/A

Filing date
13 Feb 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
5

5

Filing date
13 Feb 2024
Reporting date
31 Dec 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
13 Feb 2024
Reporting date
28 Dec 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-91059

SC 13G/A filing

Filing date
29 Jan 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-91059

SC 13G/A filing

Filing date
23 Jan 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
18 Jan 2024
Reporting date
16 Jan 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-38959

144 filing

Filing date
16 Jan 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 File 333-276393

S-8

Filing date
05 Jan 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .